Mark B. Chaskes

Dr. Mark B. Chaskes


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MWMichael Werner
Michael Werner
DYDesmond Yeoh
Desmond Yeoh
JFJudd H. Fastenberg
Judd H. Fastenberg
MCMark B. Chaskes
Mark B. Chaskes
APAron Z. Pollack
Aron Z. Pollack
CTChing Lick C. L. Tong
Ching Lick C. L. Tong
The nasoseptal flap is a workhorse reconstructive option for anterior skull base defects during endonasal surgery. This paper highlights the versatility of the nasoseptal flap. After providing a brief historical perspective, this review will focus on the relevant primary literature published in the last ten years. We will touch upon new applications of the flap, how the flap has been modified to expand its reach and robustness, and some of the current limitations. We will conclude by discussing what the future holds for improving upon the design and use of the nasoseptal flap in anterior skull base reconstruction.

24 December 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MKMeryl Beth Kravitz
Meryl Beth Kravitz
VAVivek ANNADATA
Vivek ANNADATA
BIBenjamin Ilyaev
Benjamin Ilyaev
CTChing Lick C. L. Tong
Ching Lick C. L. Tong
JFJudd H. Fastenburg
Judd H. Fastenburg
MCMark B. Chaskes
Mark B. Chaskes
Squamous cell carcinoma is the most common malignancy affecting the sinonasal tract. Local recurrence is the main pattern of treatment failure, affecting nearly half of patients treated for primary sinonasal squamous cell carcinoma (SNSCC). Due to disease rarity and heterogeneity of practices, there are limited guidelines for how to diagnose and care for these patients. This paper reviews current evidence regarding etiology, pathophysiology, diagnosis, prognostic factors, and treatment modalities of recurrent SNSCC (rSNSCC). Currently, salvage surgery offers the only durable approach for eligible patients. These resections often require robust reconstructive options due to prior surgery or radiation. Chemoradiation is offered as an adjuvant or palliative approach when surgery is not a feasible option. Emerging options such as immunotherapy and particle therapy remain an area of ongoing investigation.